Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2862924 | American Journal of Hypertension | 2006 | 9 Pages |
Abstract
Telmisartan 80 mg was consistently more effective than ramipril 10 mg in reducing both DBP and SBP during the last 6 h of the dosing interval, a measure of the early morning period when patients are at greatest risk of life-threatening cardiovascular and cerebrovascular events. Telmisartan 80 mg was also more effective than ramipril 10 mg in reducing BP throughout the entire 24-h dosing interval. Both drugs were well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yves Lacourcière, Joel M. Neutel, Gloria Davidai, Steve Koval, PRISMA II Investigators PRISMA II Investigators,